Jan-Willem Henning
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 27, 2025
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.Katarzyna J Jerzak, Sandeep Sehdev, Jean-François Boileau
|Nov 26, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer.Jeffrey Q Cao, Brae Surgeoner, Mita Manna
|Nov 26, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting.Mita Manna, Karen A Gelmon, Jean-François Boileau
|Feb 10, 2024
Treatment Patterns and Health Outcomes among Patients with HER2 IHC0/-Low Metastatic or Recurrent Breast Cancer.Eliya Farah, Chantelle Carbonell, Devon J Boyne
|Sep 27, 2023
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective.Jan-Willem Henning, Christine Brezden-Masley, Karen Gelmon
|Aug 25, 2023
Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective.Jan-Willem Henning, Jean-François Boileau, Larissa Peck
Pageof 1
Frequent Collaborators
4 joint publications
Christine Brezden-Masley
2 joint publications
David W Cescon
2 joint publications
Mita Manna
2 joint publications
Karen A Gelmon
2 joint publications
Ipshita Prakash
2 joint publications
Sandeep Sehdev
2 joint publications
Muriel Brackstone
1 joint publications
Nathalie LeVasseur
1 joint publications
Tom McFarlane
1 joint publications
Micheal McInnis
